Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation

Pharmacopsychiatry

Volumn 44, Issue 1, 2011, Pages 33-38

  Stone, J M ^a,b   Abel, K M ^c   Allin, M P G ^a   Van Haren, N ^d   Matsumoto, K ^e   McGuire, P K ^a   Fu, C H Y ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ARTICLE; CLINICAL ASSESSMENT; DISSOCIATION; DOUBLE BLIND PROCEDURE; EXCITATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SELF MONITORING; SPEECH DISORDER; TEMPORAL CORTEX; THOUGHT DISORDER; VISUAL ILLUSION;

ADULT; DOUBLE-BLIND METHOD; FEEDBACK, PSYCHOLOGICAL; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; TEMPORAL LOBE; VERBAL BEHAVIOR;

EID: 79551550415     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1267942     Document Type: Article

References (34)

1. Abel KM, Allin MP, Kucharska-Pietura K, et al. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport 2003 14 387-391
2. Allen PP, Johns LC, Fu CH, et al. Misattribution of external speech in patients with hallucinations and delusions. Schizophr Res 2004 69 277-287
3. Brammer MJ, Bullmore ET, Simmons A, et al. Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magn Reson Imaging 1997 15 763-770
4. Bremner JD, Krystal JH, Putnam FW, et al. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 1998 11 125-136
5. Bullmore E, Long C, Suckling J, et al. Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains. Hum Brain Mapp 2001 12 61-78
6. Bullmore ET, Suckling J, Overmeyer S, et al. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 1999 18 32-42
7. Bullmore ET, Brammer MJ, Rabe-Hesketh S, et al. Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp 1999 7 38-48
8. Cahill C. Psychotic experiences induced in deluded patients using distorted auditory feedback. Cognit Neuropsychiatry 1996 1 201-211
9. Corlett PR, Honey GD, Fletcher PC. From prediction error to psychosis: ketamine as a pharmacological model of delusions. J Psychopharmacol 2007 21 238-252
10. Costafreda SG, Brebion G, Allen P, et al. Affective modulation of external misattribution bias in source monitoring in schizophrenia. Psychol Med 2008 38 821-824
11. Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr Bull 1978 4 636-640
12. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry 1988 153 437-443
13. Fu CH, Vythelingum GN, Brammer MJ, et al. An fMRI study of verbal self-monitoring: neural correlates of auditory verbal feedback. Cereb Cortex 2006 16 969-977
14. Fu CH, Brammer MJ, Yaguez L, et al. Increased superior temporal activation associated with external misattributions of self-generated speech in schizophrenia. Schizophr Res 2008 100 361-363
15. Geisslinger G, Hering W, Thomann P, et al. Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth 1993 70 666-671
16. Honey GD, O'Loughlin C, Turner DC, et al. The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia. Neuropsychopharmacology 2006 31 413-423
17. Honey GD, Honey RA, O'Loughlin C, et al. Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb Cortex 2005 15 749-759
18. Honey GD, Corlett PR, Absalom AR, et al. Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J Neurosci 2008 28 6295-6303
19. Honey RA, Honey GD, O'Loughlin C, et al. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study. Neuropsychopharmacology 2004 29 1203-1214
20. Johns LC, McGuire PK. Verbal self-monitoring and auditory hallucinations in schizophrenia. Lancet 1999 353 469-470
21. Johns LC, Rossell S, Frith C, et al. Verbal self-monitoring and auditory verbal hallucinations in patients with schizophrenia. Psychol Med 2001 31 705-715
22. Keefe RS, Arnold MC, Bayen UJ, et al. Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. Psychol Med 1999 29 903-914
23. Kim JS, Kornhuber HH, Schmid-Burgk W, et al. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980 20 379-382
24. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994 51 199-214
25. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005 6 312-324
26. Mechelli A, Allen P, Amaro E Jr, et al. Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations. Hum Brain Mapp 2007 28 1213-1222
27. Moghaddam B, Adams B, Verma A, et al. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997 17 2921-2927
28. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995 52 998-1007
29. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999 33 523-533
30. Pomarol-Clotet E, Honey GD, Murray GK, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry 2006 189 173-179
31. Ryder S, Way WL, Trevor AJ. Comparative pharmacology of the optical isomers of ketamine in mice. Eur J Pharmacol 1978 49 15-23 (Pubitemid 9193621)
32. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York Thieme 1988
33. Vollenweider FX, Leenders KL, Oye I, et al. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 1997 7 25-38
34. Wolpert DM, Ghahramani Z, Jordan MI. An internal model for sensorimotor integration. Science 1995 269 1880-1882